Skip to main contentAI and Advanced
/
TRUALT · NSEBSE SENSEX74,415.8+0.11%BSE |
NIFTY 5023,266.65+0.21%NSE |
NIFTY BANK56,404.4+0.20%NSE |
NIFTY IT28,956.4-0.45%NSE |
NIFTY AUTO27,151.5+0.96%NSE |
NIFTY FMCG45,660.4+0.22%NSE |
NIFTY PHARMA26,298.15+0.58%NSE |
NIFTY 50022,622.15+0.40%NSE |
TR
NSE · Equity shares · Chemical Manufacturing40.95 · 0.75%
TruAlt Bioenergy TRUALT
NSE:INR 463.5
BSE:INR 425.7
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for TRUALT
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 422.55
Day rangeINR 407 — INR 427.5
52-week rangeINR 310.2 — INR 550
Volume4.54 L
Market cap3,953.17
P/E16.2
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)1,727.51
Net Income (INR Cr)95.95
Rev Growth (5 Year %)26.88
EPS Growth (5 Year %)16.34
P/E Ratio16.2
EPS12.3
Research path: Interpret TruAlt Bioenergy's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
TRUALTTruAlt Bioenergy1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 3,778.34 | 3,029.73 | 2,419.08 |
| Other Liabilities Total | 11.82 | 10.85 | 8.13 |
| Long Term Debt | 988.68 | 1,117.16 | 979.58 |
| Common Stock Total | 85.75 | 70.63 | 61.08 |
| Other Current Assets Total | 424.89 | 106.49 | 53.16 |
| Total Assets | 3,778.34 | 3,029.73 | 2,419.08 |
| Current Portof LT Debt/Capital Leases | 658.79 | 154.77 | 132.41 |
| Cash | 88.26 | 149.78 | 23.35 |
| Total Equity | 1,520.33 | 769 | 264.61 |
| Long Term Investments | 26.6 | 1.93 | Not available |
| Retained Earnings(Accumulated Deficit) | 1,434.58 | 238.73 | 56.63 |
| Total Common Shares Outstanding | 8.58 | 8.58 | 8.58 |
| Property/Plant/Equipment Total-Gross | 67.71 | 1,806.2 | 1,538.61 |
| Tangible Book Valueper Share Common Eq | 162.37 | 73.46 | 13.33 |
| Goodwill Net | 51.59 | 51.59 | 51.59 |
| Total Liabilities | 2,258.01 | 2,260.73 | 2,154.47 |
| Total Debt | 1,651.51 | 1,556.54 | 1,684.68 |
| Short Term Investments | 23.51 | 4.45 | 10.1 |
| Cashand Short Term Investments | 111.77 | 154.23 | 33.45 |
| Total Receivables Net | 413.66 | 536.04 | 401.91 |
| Deferred Income Tax | 110.74 | 80.03 | 105.28 |
| Accounts Receivable-Trade Net | 406.11 | 339.27 | 298.22 |
| Property/Plant/Equipment Total-Net | 2,125.12 | 1,689.56 | 1,477.6 |
| Minority Interest | 58 | Not available | Not available |
| Total Current Liabilities | 1,084.73 | 1,047.5 | 1,061.48 |
| Total Inventory | 528.43 | 264.57 | 165.38 |
| Accounts Payable | 272.11 | 485.71 | 153.62 |
| Other Currentliabilities Total | 153.82 | 125.67 | 198.75 |
| Total Long Term Debt | 992.72 | 1,122.35 | 979.58 |
| Intangibles Net | 76.38 | 87.49 | 98.74 |
| Other Long Term Assets Total | 19.9 | 0.29 | 1.31 |
| Total Current Assets | 1,478.75 | 1,062.2 | 658.13 |
| Capital Lease Obligations | 4.04 | 5.2 | 0 |
| Accumulated Depreciation Total | Not available | -116.64 | -61 |
| Accrued Expenses | Not available | 1.94 | 4 |
| Other Equity Total | Not available | 0 | 146.9 |
| Prepaid Expenses | Not available | 0.87 | 4.23 |
| Additional Paid-In Capital | Not available | 459.63 | 0 |
| Notes Payable/Short Term Debt | Not available | 279.42 | 572.69 |
| Note Receivable-Long Term | Not available | 136.67 | 131.7 |
Fundamentals
Valuation and ratios
Valuation
PEG Ratio0.64
Price to Sale Ratio2.29
Growth
Debt 5Yr CAGR %32.49
Margins
Operating Margin 12m14.17
Operating Margin 5y Avg11.91
Net Profit Margin 12m7.39
Net Profit Margin 5y5.52
Yield
Dividend Yield %0
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk36.48
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Asian Paints | INR 2,749 | 2.64 L | 58.09 | — |
| Solar Industries India | INR 18,560 | 1.68 L | 99.61 | — |
| Pidilite Industries | INR 1,671 | 1.70 L | 64.76 | — |
| SRF | INR 2,626 | 77,841.16 | 44.57 | — |
| Linde India | INR 7,105 | 61,033.66 | 110.53 | — |
Shareholding
Ownership
- Promoter
- 70.55%
- FII
- 0.57%
- MF
- 6.76%
- Other
- 22.12%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Trualt Bioenergy shares close first day strong, yet below listing price. Should you buy, sell or hold?Market news · 3 Oct 2025, 3:55 pm
Trualt Bioenergy debuted on Dalal Street with a 6.65% gain at ₹ 529, lower than the listing price of ₹ 545. Investors are advised to book partial profits, retaining some shares with a stop loss at ₹ 520. The issue was subscribed 75 times during its bidding period between September 25 and 29.
Trualt Bioenergy share price makes a positive debut, opens with 10% premium at <span class='webrupee'>₹</span>545.40 apiece on NSEMarket news · 3 Oct 2025, 10:00 am
The TruAlt Bioenergy IPO raised ₹ 750 crore, with total proceeds of ₹ 839.38 crore. Shares debuted at ₹ 545.40, reflecting strong market interest. The company is expanding its biofuels operations, focusing on second-generation ethanol, and aims to stabilize raw material supply chains.
Trualt Bioenergy IPO listing date today; GMP, experts signal strong debut of shares in stock market todayMarket news · 3 Oct 2025, 6:11 am
Trualt Bioenergy IPO listing date is 3 October 2025, and the stock will be listed on both the stock exchanges. Ahead of listing, Trualt Bioenergy IPO GMP today and analysts indicate a strong debut of shares in the stock market today.
Trualt Bioenergy IPO listing date in focus: Here’s what GMP signals about debut of sharesMarket news · 1 Oct 2025, 3:19 pm
Trualt Bioenergy IPO listing date is 3 October 2025, and the stock will be listed on both the stock exchanges. Ahead of the share debut, Trualt Bioenergy IPO GMP today signals strong debut of shares in the stock market.
Trualt Bioenergy IPO allotment date likely today. GMP, steps to check share allotment status onlineMarket news · 30 Sept 2025, 6:25 am
Trualt Bioenergy IPO allotment date is likely today, 30 September 2025. Investors can check Trualt Bioenergy IPO allotment status online through the websites of BSE and NSE, along with the official portal of the IPO registrar. Bigshare Services Pvt. Ltd. is the Urban Company IPO registrar.
IPO GMPs: Tata Capital IPO vs TruAlt Bioenergy IPO vs Jain Resource Recycling IPO — what grey market signalsMarket news · 29 Sept 2025, 12:26 pm
The primary market will be active from September 29 with five new IPOs worth over ₹ 3,852 crore. Investors are keen on Grey Market Premiums (GMPs), indicating stock performance and investor sentiment. Notable IPOs include Tata Capital, TruAlt Bioenergy, and Jain Resource Recycling.
Corporate actions
Events
- board MeetingsQuarterly Results
- annual General MeetingPOM
- board MeetingsAudited Results
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
Rusaka Markets Community
Discussion and sentiment for TruAlt Bioenergy
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
TruAlt Bioenergy Limited is an India-based biofuels company. The Company primarily engaged in the production of ethanol. It also produces extra neutral alcohol and sells dry ice and liquid carbon-dioxide, being by-products of our production processes. The Company’s products include 1G (First-generation) Ethanol, Compressed Biogas (CBG), Extra Neutral Alcohol, and Fermented Organic Manure (FOM). Its proposed products include Extra Neutral Alcohol, 2G (Second-generation) Ethanol, Sustainable Aviation Fuel, Green Hydrogen, and dispensing stations. The 1G Bioethanol is produced from biomass such as sugar-containing materials (like sugar cane juice, molasses, sugar beet etc.) and starch-containing materials (such as corn, cassava, rotten vegetables such as potatoes, damaged food grain etc.) 2G biofuels are defined as fuels produced from several feedstocks. Through its Subsidiary, Leafiniti Bioenergy Private Limited, we produce compressed biogas.
Company facts
- Industry
- Chemical Manufacturing
- Sector
- Chemical Manufacturing
- NSE Code
- TRUALT
- BSE Code
- 544545
Questions
Stock FAQ
What is the symbol and ISIN of TruAlt Bioenergy?
TruAlt Bioenergy has the symbol TRUALT and ISIN - INE0MWH01014.
What is the current price of TruAlt Bioenergy?
TruAlt Bioenergy is currently trading at INR 463.50.
What are the year high and year low of TruAlt Bioenergy?
TruAlt Bioenergy has a year high of INR 550.00 and a year low of INR 310.20.
What is the market capitalization of TruAlt Bioenergy?
TruAlt Bioenergy has a market capitalization of INR 3,953.17 crore.
What is the P/E ratio of TruAlt Bioenergy?
TruAlt Bioenergy has a P/E ratio of 16.20.
What is the dividend yield of TruAlt Bioenergy?
TruAlt Bioenergy has a dividend yield of 0.00%.
How is the financial performance of TruAlt Bioenergy based on revenue, net income, and EPS?
TruAlt Bioenergy has revenue of INR 1,727.51 crore, net income of INR 95.95 crore, and EPS of INR 16.36.
What is the book value of TruAlt Bioenergy?
TruAlt Bioenergy has a book value of NA.
What is the debt-to-equity ratio of TruAlt Bioenergy?
TruAlt Bioenergy has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of TruAlt Bioenergy?
TruAlt Bioenergy has a price-to-book ratio of NA and a price-to-sales ratio of 2.29.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.